Extrastriatal spreading of microglial activation in Parkinson’s disease: a positron emission tomography study-Reference-Cited by-同舟云学术

Extrastriatal spreading of microglial activation in Parkinson’s disease: a positron emission tomography study

Published:2016-06-14 Issue:8 Volume:30 Page:579-587
ISSN:0914-7187
Container-title:Annals of Nuclear Medicine
language:en
Short-container-title:Ann Nucl Med

Author:

Terada Tatsuhiro,Yokokura Masamichi,Yoshikawa Etsuji,Futatsubashi Masami,Kono Satoshi,Konishi Takashi,Miyajima Hiroaki,Hashizume Takanori,Ouchi Yasuomi

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12149-016-1099-2.pdf

Reference29 articles.

1. Muller CM, de Vos RA, Maurage CA, Thal DR, Tolnay M, Braak H. Staging of sporadic Parkinson disease-related alpha-synuclein pathology: inter- and intra-rater reliability. J Neuropathol Exp Neurol. 2005;64:623–8.

2. Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, et al. Microglial activation and dopamine terminal loss in early Parkinson’s disease. Ann Neurol. 2005;57:168–75.

3. Banati RB, Daniel SE, Blunt SB. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson’s disease. Mov Disord. 1998;13:221–7.

4. McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s disease brains. Neurology. 1988;38:1285–91.

5. Ouchi Y, Yagi S, Yokokura M, Sakamoto M. Neuroinflammation in the living brain of Parkinson’s disease. Parkinsonism Relat Disord. 2009;15(Suppl 3):S200–4.

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The humoral immune landscape in Parkinson's disease: Unraveling antibody and B cell changes;Cell Biochemistry and Function;2024-08-27

2. Detrimental but Not Doomed—Glial Activation in Rapid Eye Movement Sleep Behavior Disorder;Movement Disorders;2024-08

3. Immunotherapy: An emerging treatment option for neurodegenerative diseases;Drug Discovery Today;2024-05

4. Neuroinflammation following anti-parkinsonian drugs in early Parkinson’s disease: a longitudinal PET study;Scientific Reports;2024-02-27

5. Radionuclide Imaging of the Neuroanatomical and Neurochemical Substrate of Cognitive Decline in Parkinson’s Disease;Nuclear Medicine and Molecular Imaging;2024-02-15